Frontiers in Immunology (Nov 2022)
Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy
Abstract
No abstracts available.Keywords